XuY, HysajO, QiX, et al.Natural history of thyroid function in ageing: An individual participant data analysis of 137 488 participants from 31 prospective cohort studies. Lancet Diabetes Endocrinol2026;14(6): 485-497; doi: 10.1016/S2213-8587(26)00009-4.
2.
JansenHI, DirksNF, HillebrandJJ, et al.Age-specific reference intervals for thyroid-stimulating hormones and free thyroxine to optimize diagnosis of thyroid disease. Thyroid2024;34(11):1346-1355; doi: 10.1089/thy.2024.0346.
3.
SurksMI, HollowellJG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab2007;92(12):4575-4582; doi: 10.1210/jc.2007-1499.
4.
JonklaasJ, BiancoAC, BauerAJ, American Thyroid Association Task Force on Thyroid Hormone Replacement. et al.; Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid2014;24:1670-1751; doi: 10.1089/thy.2014.0028.
5.
CentanniM, DuntasL, Feldt-RasmussenU, et al.ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism. Eur Thyroid J2025;14(4):e250123; doi: 10.1530/ETJ-25-0123.
6.
ZijlstraLE, JukemaJW, WestendorpRGJ, et al.Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: Pooled individual results of two randomised controlled trials. Front Endocrinol (Lausanne)2021;12:674841; doi: 10.3389/fendo.2021.674841.
7.
StottDJ, RodondiN, KearneyPM, et al.Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med2017;376(26):2534-2544; doi: 10.1056/NEJMoa1603825.
